31
Jul

In this week’s EuroBiotech Report, the last week of July was a massive one for European biotech IPOs, with BioBlast Pharma, Innocoll, Macrocure, Mapi Pharma and VBL Therapeutics all heading to the Nasdaq. All of the companies struggled though. And more.

…read more

Source: Almirall seeks dermatology deals, Euro biotech IPOs fall short, Cellectis increases CAR-T focus

    

0 No comments